Jaffetilchin Investment Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

Jaffetilchin Investment Partners’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,126	Closed	-$471K	–	319
2018 Q4	$471K	Buy	5,126 +177	+4%	+$17.9K	0.12%	134
2018 Q3	$545K	Sell	4,949 -88	-2%	-$9.16K	0.12%	145
2018 Q2	$470K	Sell	5,037 -178	-3%	-$15.3K	0.1%	173
2018 Q1	$433K	Buy	5,215 +229	+5%	+$20.3K	0.1%	181
2017 Q4	$454K	Sell	4,986 -229	-4%	-$19K	0.15%	122
2017 Q3	$397K	Buy	5,215 +229	+5%	+$17.3K	0.09%	198
2017 Q2	$374K	Buy	+4,986	New	+$346K	0.13%	138

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Jaffetilchin Investment Partners's PRAH Position: Q1 2019 in Review

Jaffetilchin Investment Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2019, closing a stake of 5,126 shares — an estimated $471K sold.

Jaffetilchin Investment Partners first reported a position in PRAH in Q2 2017 and held it in 7 quarters. The position peaked at $545K in Q3 2018. 354 funds tracked by Wall St. Rank hold PRAH as of Q1 2019.

Jaffetilchin Investment Partners reported no remaining PRA Health Sciences, Inc. position as of Q1 2019 after selling out during the quarter.
Jaffetilchin Investment Partners sold 5,126 PRA Health Sciences, Inc. shares in Q1 2019, an estimated $471K.
Jaffetilchin Investment Partners first reported a position in PRA Health Sciences, Inc. in Q2 2017 and held it in 7 quarters.
Jaffetilchin Investment Partners's PRA Health Sciences, Inc. position peaked at $545K in Q3 2018.
354 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2019.

Based on Jaffetilchin Investment Partners's 13F filing for Q1 2019, filed 13 May 2019.